—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Crinetics Pharmaceuticals Inc（CRNX）— 同業公司組

數據截至2026-10-05 — 評分每個交易日晚間重新計算。分組標準＝首先為共同的Closelook指數成分，其次為產業。Closelook研究日記，不構成投資建議。

Crinetics Pharmaceuticals Inc的Closelook綜合評分為49/100，在同業公司組內排名第7位（共7家）——組內評分最高的是BB Biotech AG（73/100）。

名稱綜合動能品質估值訊號距52週高點
CRNX Crinetics Pharmaceuticals Inc4998214ok0.1%
BION.SW BB Biotech AG73619680info13.1%
ONC BeiGene, Ltd.64786632ok6.1%
CAI Caris Life Sciences, Inc. Common Stock61866331ok9.7%
PTGX Protagonist Therapeutics Inc59746211info12.5%
REGN Regeneron Pharmaceuticals Inc59537252bull14.4%
CORT Corcept Therapeutics Incorporated58965024ok3.4%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板。

FAQ · from the current data · as of 2026-10-05

Quick answers

Crinetics Pharmaceuticals Inc在Closelook涵蓋範圍內的同業公司有哪些？

分組首先根據共同的Closelook指數成分，其次根據產業：BB Biotech AG (BION.SW)、BeiGene, Ltd. (ONC)、Caris Life Sciences, Inc. Common Stock (CAI)、Protagonist Therapeutics Inc (PTGX)、Regeneron Pharmaceuticals Inc (REGN)、Corcept Therapeutics Incorporated (CORT)。

CRNX相對同業公司的評分如何？

Crinetics Pharmaceuticals Inc的綜合評分為49/100，組內排名第7位（共7家），截至2026-10-05；組內最高綜合評分為BB Biotech AG（73/100）。Closelook評分為研究日記讀數，不構成評等或投資建議。

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.